Skip to content

Study · Animal study (in vivo) · rat · 2002

16 results

Effects of long-term treatment with the luteinizing hormone-releasing hormone (LHRH) agonist Decapeptyl and the LHRH antagonist Cetrorelix on the levels of pituitary LHRH receptors and their mRNA expression in rats.

Horvath JE, Bajo AM, Schally AV, Kovacs M, Herbert F, Groot K

Proceedings of the National Academy of Sciences of the United States of America30 Oct 2002Cited by 27 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study16

14 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Mechanism

    In female rats, Decapeptyl microcapsules increased serum LH.

    In plain wordsIn female rats, Decapeptyl microcapsules increased serum LH.

    Outcome
    IncreaseFemale serum LH
    Study

    ratn: not reported in source

    Pituitary-gonadal axis
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones
    Studied dose
    25 microg/day · 30 daysAs given in this study (rat).

    Source sentences

    Summary
    Decapeptyl microcapsules elevated serum LH in female rats, but decreased it in male rats.
  2. 02AnimalAnimal study (in vivo)Mechanism

    In male rats, Decapeptyl microcapsules decreased serum LH.

    In plain wordsIn male rats, Decapeptyl microcapsules decreased serum LH.

    Outcome
    DecreaseMale serum LH
    Study

    ratn: not reported in source

    Pituitary-gonadal axis
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones
    Studied dose
    25 microg/day · 30 daysAs given in this study (rat).

    Source sentences

    Summary
    Decapeptyl microcapsules elevated serum LH in female rats, but decreased it in male rats.
  3. 03AnimalAnimal study (in vivo)Mechanism

    In female rats, Decapeptyl microcapsules reduced pituitary LHRH receptor mRNA to 41% on day 10 and 56-65% on day 30.

    In plain wordsIn female rats, Decapeptyl microcapsules reduced pituitary receptor gene expression on days 10 and 30.

    Outcome
    DecreaseFemale pituitary receptor mRNA
    Study

    ratn: not reported in source

    Pituitary-gonadal axis
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones
    Studied dose
    25 microg/day · 30 daysAs given in this study (rat).

    Measurements

    LHRH-R mRNA
    41%
    day 10
    LHRH-R mRNA
    56 to 65%
    day 30

    Source sentences

    Summary
    LHRH-R mRNA expression in female pituitaries was reduced to 41% and 56-65% on days 10 and 30, respectively, whereas LHRH-R protein was 64% of control on day 10 and returned to pretreatment levels on day 30.
    2 context sentences
    Summary · context
    Decapeptyl microcapsules elevated serum LH in female rats, but decreased it in male rats.
    Summary · context
    The effects of depot formulations of the luteinizing hormone-releasing hormone (LHRH) agonist Decapeptyl (25 microg/day) for 30 days or LHRH antagonist Cetrorelix pamoate (100 microg/day) for 30 days and daily injections of 100 microg of Decapeptyl for 10 days on the expression of mRNA for pituitary…
  4. 04AnimalAnimal study (in vivo)Mechanism

    In female rats, Decapeptyl microcapsules reduced pituitary LHRH receptor protein to 64% of control on day 10.

    In plain wordsIn female rats, Decapeptyl microcapsules reduced pituitary receptor protein compared with control on day 10.

    Outcome
    DecreaseFemale receptor protein at day 10
    Study

    ratn: not reported in source

    Pituitary-gonadal axis
    Comparator
    Control
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones
    Studied dose
    25 microg/day · 30 daysAs given in this study (rat).

    Source sentences

    Summary
    LHRH-R mRNA expression in female pituitaries was reduced to 41% and 56-65% on days 10 and 30, respectively, whereas LHRH-R protein was 64% of control on day 10 and returned to pretreatment levels on day 30.
    2 context sentences
    Summary · context
    Decapeptyl microcapsules elevated serum LH in female rats, but decreased it in male rats.
    Summary · context
    The effects of depot formulations of the luteinizing hormone-releasing hormone (LHRH) agonist Decapeptyl (25 microg/day) for 30 days or LHRH antagonist Cetrorelix pamoate (100 microg/day) for 30 days and daily injections of 100 microg of Decapeptyl for 10 days on the expression of mRNA for pituitary…
  5. 05AnimalAnimal study (in vivo)Mechanism

    In female rats, pituitary LHRH receptor protein returned to pretreatment levels on day 30 during Decapeptyl microcapsule treatment.

    In plain wordsIn female rats, pituitary receptor protein returned to pretreatment levels on day 30 during Decapeptyl microcapsule treatment.

    Outcome
    No significant changeFemale receptor protein at day 30
    Study

    ratn: not reported in source

    Pituitary-gonadal axis
    Comparator
    Pretreatment levels
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones
    Studied dose
    25 microg/day · 30 daysAs given in this study (rat).

    Source sentences

    Summary
    LHRH-R mRNA expression in female pituitaries was reduced to 41% and 56-65% on days 10 and 30, respectively, whereas LHRH-R protein was 64% of control on day 10 and returned to pretreatment levels on day 30.
    2 context sentences
    Summary · context
    Decapeptyl microcapsules elevated serum LH in female rats, but decreased it in male rats.
    Summary · context
    The effects of depot formulations of the luteinizing hormone-releasing hormone (LHRH) agonist Decapeptyl (25 microg/day) for 30 days or LHRH antagonist Cetrorelix pamoate (100 microg/day) for 30 days and daily injections of 100 microg of Decapeptyl for 10 days on the expression of mRNA for pituitary…
  6. 06AnimalAnimal study (in vivo)Mechanism

    In male rats, Decapeptyl microcapsules reduced pituitary receptor mRNA to 58% on day 30.

    In plain wordsIn male rats, Decapeptyl microcapsules reduced pituitary receptor gene expression on day 30.

    Outcome
    DecreaseMale receptor mRNA
    Study

    ratn: not reported in source

    Pituitary-gonadal axis
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones
    Studied dose
    25 microg/day · 30 daysAs given in this study (rat).

    Source sentences

    Summary
    Decapeptyl microcapsules reduced LHRH-R mRNA expression in male pituitaries to 58% on day 30 but not LHRH-R protein.
  7. 07AnimalAnimal study (in vivo)Mechanism

    In male rats, Decapeptyl microcapsules did not reduce pituitary receptor protein.

    In plain wordsIn male rats, Decapeptyl microcapsules did not reduce pituitary receptor protein.

    Outcome
    No significant changeMale receptor protein
    Study

    ratn: not reported in source

    Pituitary-gonadal axis
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones
    Studied dose
    25 microg/day · 30 daysAs given in this study (rat).

    Source sentences

    Summary
    Decapeptyl microcapsules reduced LHRH-R mRNA expression in male pituitaries to 58% on day 30 but not LHRH-R protein.
  8. 08AnimalAnimal study (in vivo)Mechanism

    In female rats, daily Decapeptyl injections desensitized LH responses.

    In plain wordsIn female rats, daily Decapeptyl injections reduced LH responsiveness.

    Outcome
    DecreaseFemale LH response desensitization
    Study

    ratn: not reported in source

    Pituitary-gonadal axis
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones
    Studied dose
    100 microg daily · injection · 10 daysAs given in this study (rat).

    Source sentences

    Summary
    Daily injections of Decapeptyl caused a desensitization of LH responses in female rats, while raising LHRH-R mRNA expression in female rats by 23% and LHRH-R protein levels by 119%.
  9. 09AnimalAnimal study (in vivo)Mechanism

    In female rats, daily Decapeptyl injections increased receptor mRNA expression by 23%.

    In plain wordsIn female rats, daily Decapeptyl injections increased receptor gene expression by 23%.

    Outcome
    IncreaseFemale receptor mRNA after daily injections
    Study

    ratn: not reported in source

    Pituitary-gonadal axis
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones
    Studied dose
    100 microg daily · injection · 10 daysAs given in this study (rat).

    Source sentences

    Summary
    Daily injections of Decapeptyl caused a desensitization of LH responses in female rats, while raising LHRH-R mRNA expression in female rats by 23% and LHRH-R protein levels by 119%.
  10. 10AnimalAnimal study (in vivo)Mechanism

    In female rats, daily Decapeptyl injections increased receptor protein by 119%.

    In plain wordsIn female rats, daily Decapeptyl injections increased receptor protein by 119%.

    Outcome
    IncreaseFemale receptor protein after daily injections
    Study

    ratn: not reported in source

    Pituitary-gonadal axis
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones
    Studied dose
    100 microg daily · injection · 10 daysAs given in this study (rat).

    Source sentences

    Summary
    Daily injections of Decapeptyl caused a desensitization of LH responses in female rats, while raising LHRH-R mRNA expression in female rats by 23% and LHRH-R protein levels by 119%.
  11. 11AnimalAnimal study (in vivo)Mechanism

    In ovariectomized rats, Decapeptyl reduced elevated receptor protein levels.

    In plain wordsIn ovariectomized rats, Decapeptyl reduced elevated receptor protein levels.

    Outcome
    DecreaseReceptor protein after ovariectomy
    Study

    ratn: not reported in source

    Pituitary-gonadal axis
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones
    Studied dose
    100 microg/day · 10 daysAs given in this study (rat).

    Source sentences

    Summary
    Elevated LHRH-R protein levels of ovariectomized rats were reduced after 10-day treatment with Cetrorelix or 100 microg/day Decapeptyl.
  12. 12AnimalAnimal study (in vivo)Mechanism

    In rats, Decapeptyl inhibited serum LH less than cetrorelix.

    In plain wordsIn rats, Decapeptyl reduced serum LH less than cetrorelix.

    Outcome
    IncreaseSerum LH versus cetrorelix
    Study

    ratn: not reported in source

    Pituitary-gonadal axis
    Comparator
    Cetrorelix
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The inhibitory effect of Cetrorelix on serum LH, pituitary LHRH-R mRNA, and LHRH-R protein was greater than that of Decapeptyl.
  13. 13AnimalAnimal study (in vivo)Mechanism

    In rats, Decapeptyl inhibited pituitary receptor mRNA less than cetrorelix.

    In plain wordsIn rats, Decapeptyl reduced pituitary receptor gene expression less than cetrorelix.

    Outcome
    IncreaseReceptor mRNA versus cetrorelix
    Study

    ratn: not reported in source

    Pituitary-gonadal axis
    Comparator
    Cetrorelix
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The inhibitory effect of Cetrorelix on serum LH, pituitary LHRH-R mRNA, and LHRH-R protein was greater than that of Decapeptyl.
  14. 14AnimalAnimal study (in vivo)Mechanism

    In rats, Decapeptyl inhibited receptor protein less than cetrorelix.

    In plain wordsIn rats, Decapeptyl reduced receptor protein less than cetrorelix.

    Outcome
    IncreaseReceptor protein versus cetrorelix
    Study

    ratn: not reported in source

    Pituitary-gonadal axis
    Comparator
    Cetrorelix
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The inhibitory effect of Cetrorelix on serum LH, pituitary LHRH-R mRNA, and LHRH-R protein was greater than that of Decapeptyl.

Studies that did not test the peptide alone2

In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Triptorelin (Trelstar, Decapeptyl).

  1. 15AnimalNot a test of Triptorelin (Trelstar, Decapeptyl) aloneAnimal study (in vivo)Mechanism

    In rats, sex steroid concentrations decreased in all analog-treated groups, including Decapeptyl groups.

    In plain wordsIn rats, sex steroid levels decreased in all analog-treated groups, including Decapeptyl groups.

    Outcome
    DecreaseSerum sex steroids
    Study

    ratn: not reported in source

    Pituitary-gonadal axis
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones

    Source sentences

    Summary
    Serum sex steroid concentrations and the weights of the reproductive organs were greatly reduced in all groups treated with analogs, demonstrating an efficient blockade of the pituitary-gonadal axis.

    In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Triptorelin (Trelstar, Decapeptyl).

  2. 16AnimalNot a test of Triptorelin (Trelstar, Decapeptyl) aloneAnimal study (in vivo)Mechanism

    In rats, reproductive organ weights decreased in all analog-treated groups, including Decapeptyl groups.

    In plain wordsIn rats, reproductive organ weights decreased in all analog-treated groups, including Decapeptyl groups.

    Outcome
    DecreaseReproductive organ weights
    Study

    ratn: not reported in source

    Pituitary-gonadal axis
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones

    Source sentences

    Summary
    Serum sex steroid concentrations and the weights of the reproductive organs were greatly reduced in all groups treated with analogs, demonstrating an efficient blockade of the pituitary-gonadal axis.

    In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Triptorelin (Trelstar, Decapeptyl).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    27 Oct 2026, 16:35 UTC

    Study data updated · source update from Europe PMC

  2. Version 2

    22 Oct 2026, 02:26 UTC

    Study results updated

  3. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.